These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 11137254)
21. Early pregnancy termination in rats immunized with denatured chicken riboflavin carrier protein. Karande AA; Adiga PR Indian J Biochem Biophys; 1991; 28(5-6):476-80. PubMed ID: 1812085 [TBL] [Abstract][Full Text] [Related]
22. A comparison of two dissimilar monoclonal antibodies that are directed to a common epitope in the reduced and carboxymethylated chicken riboflavin carrier protein. Lobo SC; Karande AA; Adiga PR Immunol Invest; 1998 Dec; 27(6):339-53. PubMed ID: 9845420 [TBL] [Abstract][Full Text] [Related]
23. Expression, purification, and characterization of minimized chicken riboflavin carrier protein from a synthetic gene in Escherichia coli. Subramanian S; Kondaiah P; Radhakantha Adiga P Protein Expr Purif; 2002 Nov; 26(2):284-9. PubMed ID: 12406683 [TBL] [Abstract][Full Text] [Related]
24. Improved presentation of antigenic sites in enzyme-linked immunosorbent assay: antigenicity of reduced and carboxymethylated riboflavin carrier protein. Pereira J; Brahmbhatt ND; Natraj U Indian J Biochem Biophys; 1993 Aug; 30(4):209-13. PubMed ID: 7506230 [TBL] [Abstract][Full Text] [Related]
25. Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs. Yu M; Zeng W; Pagnon J; Walker J; Ghosh S; Wang LF; Jackson DC Vaccine; 2005 Aug; 23(37):4589-97. PubMed ID: 15927323 [TBL] [Abstract][Full Text] [Related]
26. Development of mouse-specific contraceptive vaccines: infertility in mice immunized with peptide and polyepitope antigens. Hardy CM; Clydesdale G; Mobbs KJ Reproduction; 2004 Oct; 128(4):395-407. PubMed ID: 15454634 [TBL] [Abstract][Full Text] [Related]
27. Development and characterization of monoclonal antibodies to chicken riboflavin carrier protein. Deshmukh A; Gani M; Natraj U Hybridoma; 2000 Oct; 19(5):387-95. PubMed ID: 11128028 [TBL] [Abstract][Full Text] [Related]
28. A synthetic gonadotropin-releasing hormone (GnRH) vaccine for control of fertility and hormone dependent diseases without any adjuvant. Jinshu X; Jingjing L; Duan P; Zheng Z; Ding M; Jie W; Rongyue C; Zhuoyi H; Roque RS Vaccine; 2005 Sep; 23(40):4834-43. PubMed ID: 15996796 [TBL] [Abstract][Full Text] [Related]
29. Pregnancy suppression by active immunization against gestation-specific riboflavin carrier protein. Murty CV; Adiga PR Science; 1982 Apr; 216(4542):191-3. PubMed ID: 7063879 [TBL] [Abstract][Full Text] [Related]
30. Folded conformations of antigenic peptides from riboflavin carrier protein in aqueous hexafluoroacetone. Bhattacharjya S; Awasthi SK; Adiga PR; Balaram P Protein Sci; 1998 Jan; 7(1):123-31. PubMed ID: 9514267 [TBL] [Abstract][Full Text] [Related]
31. Cell activation and immunogenicity. Benjamini E; Wan AM; Langton BC; Andria ML Dev Biol Stand; 1986; 63():29-39. PubMed ID: 3527819 [TBL] [Abstract][Full Text] [Related]
32. Novel Sperm and Gonadotropin-releasing Hormone-based Recombinant Fusion Protein: Achievement of 100% Contraceptive Efficacy by Co-immunization of Male and Female Mice. Minhas V; Shrestha A; Wadhwa N; Singh R; Gupta SK Mol Reprod Dev; 2016 Dec; 83(12):1048-1059. PubMed ID: 27676172 [TBL] [Abstract][Full Text] [Related]
33. Contraceptive vaccines based on the zona pellucida glycoproteins for dogs and other wildlife population management. Gupta SK; Srinivasan VA; Suman P; Rajan S; Nagendrakumar SB; Gupta N; Shrestha A; Joshi P; Panda AK Am J Reprod Immunol; 2011 Jul; 66(1):51-62. PubMed ID: 21501280 [TBL] [Abstract][Full Text] [Related]
34. In search of the active PZP epitope in white-tailed deer immunocontraception. Miller LA; Killian GJ Vaccine; 2002 Jun; 20(21-22):2735-42. PubMed ID: 12034100 [TBL] [Abstract][Full Text] [Related]
35. Immunocontraceptive effect of Izumo and enhancement by combination vaccination. Naz RK Mol Reprod Dev; 2008 Feb; 75(2):336-44. PubMed ID: 17676591 [TBL] [Abstract][Full Text] [Related]
36. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate. Kaliyaperumal A; Chauhan VS; Talwar GP; Raghupathy R Eur J Immunol; 1995 Dec; 25(12):3375-80. PubMed ID: 8566026 [TBL] [Abstract][Full Text] [Related]
37. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781 [TBL] [Abstract][Full Text] [Related]
38. Strategies for designing an immunocontraceptive vaccine based on zona pellucida synthetic peptides and recombinant antigen. Kaul R; Afzalpurkar A; Gupta SK J Reprod Fertil Suppl; 1996; 50():127-34. PubMed ID: 8984175 [TBL] [Abstract][Full Text] [Related]
39. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479 [TBL] [Abstract][Full Text] [Related]